Massachusetts Financial Services Co. MA Has $34.54 Million Stock Position in Option Care Health, Inc. $OPCH

Massachusetts Financial Services Co. MA raised its stake in Option Care Health, Inc. (NASDAQ:OPCH) by 2.7% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 1,244,321 shares of the company’s stock after buying an additional 33,019 shares during the quarter. Massachusetts Financial Services Co. MA’s holdings in Option Care Health were worth $34,542,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in OPCH. MeadowBrook Investment Advisors LLC bought a new stake in Option Care Health in the 3rd quarter valued at $105,000. TD Private Client Wealth LLC raised its stake in shares of Option Care Health by 32.4% in the 3rd quarter. TD Private Client Wealth LLC now owns 10,592 shares of the company’s stock valued at $294,000 after purchasing an additional 2,592 shares during the period. Nordea Investment Management AB lifted its holdings in shares of Option Care Health by 1.9% in the third quarter. Nordea Investment Management AB now owns 97,070 shares of the company’s stock valued at $2,674,000 after purchasing an additional 1,780 shares in the last quarter. State of Alaska Department of Revenue lifted its holdings in shares of Option Care Health by 49.0% in the third quarter. State of Alaska Department of Revenue now owns 27,349 shares of the company’s stock valued at $758,000 after purchasing an additional 8,998 shares in the last quarter. Finally, Nisa Investment Advisors LLC boosted its position in shares of Option Care Health by 41.2% during the third quarter. Nisa Investment Advisors LLC now owns 5,224 shares of the company’s stock worth $145,000 after buying an additional 1,523 shares during the period. Institutional investors own 98.05% of the company’s stock.

Insider Activity at Option Care Health

In other news, Director Harry M. Jansen Kraemer, Jr. acquired 38,000 shares of the stock in a transaction dated Monday, November 3rd. The shares were bought at an average cost of $25.98 per share, for a total transaction of $987,240.00. Following the purchase, the director directly owned 413,390 shares of the company’s stock, valued at approximately $10,739,872.20. This trade represents a 10.12% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.64% of the stock is currently owned by company insiders.

Option Care Health Price Performance

NASDAQ:OPCH opened at $36.59 on Friday. The stock has a market capitalization of $5.81 billion, a PE ratio of 29.04, a P/E/G ratio of 2.16 and a beta of 0.80. Option Care Health, Inc. has a 1-year low of $24.24 and a 1-year high of $36.74. The firm has a fifty day simple moving average of $32.10 and a 200 day simple moving average of $29.68. The company has a current ratio of 1.56, a quick ratio of 1.05 and a debt-to-equity ratio of 0.85.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on OPCH. Deutsche Bank Aktiengesellschaft lifted their target price on Option Care Health from $31.00 to $36.00 and gave the company a “buy” rating in a research report on Tuesday, December 9th. Stephens raised shares of Option Care Health to a “strong-buy” rating in a research report on Thursday, December 11th. Truist Financial set a $40.00 target price on shares of Option Care Health in a report on Tuesday, January 13th. Morgan Stanley raised their target price on shares of Option Care Health from $35.00 to $38.00 and gave the company an “overweight” rating in a research report on Tuesday, January 13th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Option Care Health in a research report on Monday, December 29th. One research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat, Option Care Health presently has a consensus rating of “Moderate Buy” and a consensus target price of $37.50.

Option Care Health Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.